Intellipharmaceutics International Inc 's ability to collect accounts receivable sequentially worsen to 6.39, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Intellipharmaceutics International Inc 's Accounts Receivable average collection period in the Aug 31 2023 quarter, has increased to 57 days, from 56 days, in the May 31 2023 quarter.

If we take a look into Healthcare sector 16 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 210, from overall ranking in the second quarter 2023 at 4209.

What is Receivable Turnover Ratio?
What is Intellipharmaceutics International Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

IPCIF Receivables Turnover Ratio	(Aug 31 2023) III. Quarter	(May 31 2023) II. Quarter	(Feb 28 2023) I. Quarter	(Nov 30 2022) IV. Quarter	0 III. Quarter
Y / Y Receivable Change	-	55312.29 %	183.15 %	-	-
Y / Y Revenue Change	-	-	291.25 %	-	-79.59 %
Receivable Turnover Ratio (TTM)	6.39	6.53	7.71	8.79	5.4
IPCIF's Total Ranking	# 210	# 4209	# 0	#	#
Accounts Receivable average collection period days	57	56	47	42	68
Seq. Receivable Change	-	57.7 %	35037.38 %	0 %	0 %
Seq. Revenue Change	-	47.15 %	396.51 %	244.7 %	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 7
Healthcare Sector	# 17
Overall Market	# 210

Receivable Turnover Ratio Statistics
High	Average	Low
109.18	44.13	1.04
(Nov 30 2022)		(Nov 30 2013)

IPCIF Company Profile • Back to IPCIF Efficiency Comparisons • Compare IPCIF Receivables Turnover Ratio to its Competitors

Financial Statements
Intellipharmaceutics International Inc 's Accounts Receivable	$ 0 Millions	Visit IPCIF's Balance sheet
Intellipharmaceutics International Inc 's Sales TTM	$ 1 Millions	Visit IPCIF's Income Statement
Sources of IPCIF's Revenues		Visit IPCIF's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
IPCIF's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
IPCIF's Growth Rates	IPCIF's Roa	IPCIF's Inventory Turnover Ratio	IPCIF's Dividend Comparisons
IPCIF's Profitability Ratios	IPCIF's Roi	IPCIF's Asset Turnover Ratio	IPCIF's Dividend Growth
IPCIF's Valuation Ratios	IPCIF's Roe	IPCIF's Financial Strength Ratios	IPCIF's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Aug 31 2023, within Healthcare Sector

Receivable Turnover Ratio

Revenues for 12 Months ending Aug 31 2023

Receivable at quarter ending Aug 31 2023

Date modified: 2026-09-12T06:20:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.